Description
Cartel Labz – 5 Amino 1MQ 100 mg – 60 Capsules is listed in the uploaded wholesale sheet as a 60-capsule product. The reported active strength is 100 mg. This description is written in English for WooCommerce catalogue preparation, regulatory review, and product identification. It is not medical advice, a dosage guide, a cycle plan, or proof that the item may be lawfully sold in any country.
Reported Product Information
| Field | Reported data |
|---|---|
| Product name | 5 Amino 1MQ |
| Aliases | 5-amino-1-methylquinolinium |
| Ingredient class | NNMT-inhibitor research compound |
| Reported strength | 100 mg |
| Package size | 60 capsules |
| Source category | PEPTIDES |
| Review status | Research peptide or small molecule; product-specific authorisation not verified |
Product Profile
5 Amino 1MQ is commonly associated with 5-amino-1-methylquinolinium, a research compound studied as an inhibitor of nicotinamide N-methyltransferase, abbreviated NNMT. It is a small molecule, not a peptide or ordinary supplement ingredient.
How It Works
NNMT participates in nicotinamide metabolism and methyl-donor balance. Inhibiting NNMT may influence cellular NAD-related metabolism, adipose-tissue biology, energy balance, and metabolic signalling in experimental models. These mechanisms are not equivalent to approved weight-loss or performance claims.
The practical effect of any capsule depends on the verified ingredient, salt or ester form, purity, excipients, dissolution, stability, route of administration, user health status, and interactions with medicines or other supplements. A wholesale spreadsheet cannot confirm those points.
Evidence, Safety and Compliance
Most evidence is preclinical. Human safety, effective exposure, long-term effects, and authorised consumer use have not been established for a 100 mg capsule product.
Safety Considerations
Potential concerns include unpredictable metabolic effects, interaction with medicines affecting energy metabolism, unknown liver or kidney burden, and quality issues common to unapproved research compounds.
People with medical conditions, pregnancy-related considerations, endocrine disorders, cardiovascular risk, liver or kidney disease, or prescription medicine use should seek qualified professional advice. The product should not be promoted as diagnosing, treating, curing, or preventing disease.
Sports and Legal Review
Athletes should treat experimental metabolic modulators as high risk until anti-doping status and contents are independently verified. Before import, advertising, or sale, confirm the legal classification in every destination market. Many products in this catalogue are research compounds, hormone modulators, peptides, or designer steroid style products rather than ordinary supplements.




